Loading insider details...
Latest Form 4 (Nov 4, 2026): Grant/Award of 160,000 ALT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Altimmune, Inc. (ALT) | Grant/Award | 160,000 | n/a |
| Jan 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 4,803 | n/a |
| Jan 18, 2024 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Tax Withholding | 1,067 | $260.3K |
| Jan 19, 2023 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 15,001 | n/a |
| Feb 25, 2022 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 45,000 | n/a |
| Nov 3, 2021 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 5,000 | n/a |
| May 19, 2021 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 65,000 | n/a |